Clinical Trial Update: Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating oxytocin for irritability and emotional dysregulation in mood disorders and disruptive behavior disorders has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disruptive Behavior Disorders
• Mood Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Nebraska | Conditions: Mood Disorder, Disruptive Behavior Disorders | Phase 2 | Status: COMPLETED | Results posted: 2022-08-30